NYLIM
SAGE

New York Life Investment Management’s Sage Therapeutics SAGE Stock Holding History

New York Life Investment Management’s Portfolio SAGE Stock Details SAGE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-19,151
Closed -$359K – 1232
2024
Q1 		$359K Buy
+19,151
New +$359K ﹤0.01% 1232